Balyasny Asset Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,107
| Closed | -$289K | – | 2347 |
|
|
2024
Q2 | $289K | Buy |
34,107
+2,822
| +9% | +$23.9K | ﹤0.01% | 1614 |
|
|
2024
Q1 | $281K | Buy |
+31,285
| New | +$281K | ﹤0.01% | 1676 |
|
|
2023
Q4 | – | Sell |
-13,699
| Closed | -$118K | – | 2260 |
|
|
2023
Q3 | $118K | Buy |
+13,699
| New | +$118K | ﹤0.01% | 1628 |
|
|
2018
Q2 | – | Sell |
-65,149
| Closed | -$1.58M | – | 1902 |
|
|
2018
Q1 | $1.58M | Sell |
65,149
-23,543
| -27% | -$571K | 0.01% | 884 |
|
|
2017
Q4 | $2.47M | Sell |
88,692
-91,908
| -51% | -$2.56M | 0.01% | 870 |
|
|
2017
Q3 | $6.18M | Buy |
180,600
+24,850
| +16% | +$851K | 0.02% | 536 |
|
|
2017
Q2 | $6.21M | Sell |
155,750
-61,674
| -28% | -$2.46M | 0.03% | 571 |
|
|
2017
Q1 | $8.01M | Buy |
217,424
+35,059
| +19% | +$1.29M | 0.04% | 493 |
|
|
2016
Q4 | $5.81M | Buy |
+182,365
| New | +$5.81M | 0.03% | 525 |
|